Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa824de559626791a8de5e82900b2bd1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 |
filingDate |
2006-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e853e6745ca957d71caf1ce1189712b |
publicationDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20130126746-A |
titleOfInvention |
Use of delmofinol in the treatment of acne |
abstract |
(I) The present invention relates to the use of a morpholino compound of the general formula or a pharmaceutically acceptable salt thereof in the preparation of a composition for treating acne: (I) wherein R 1 is 2- or 3- of the morpholino ring. A straight or branched chain alkyl group containing from 8 to 16 carbon atoms in position, and R 2 is a straight or branched chain alkyl group containing from 2 to 20 carbon atoms substituted with a hydroxyl group except for the alpha-position. |
priorityDate |
2005-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |